Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AZN.ST Stock Summary
Top 10 Correlated ETFs
AZN.ST
In the News
AZN.ST Financial details
Company Rating
Strong Buy
Market Cap
2447.23B
Income
4.7B
Revenue
43.84B
Book val./share
23.1
Cash/share
4.17
Dividend
2.39
Dividend %
1.63%
Employees
83.5K
Optionable
No
Shortable
Yes
Earnings
27 Apr 2023
P/E
48.19
Forward P/E
-
PEG
0.13
P/S
5.17
P/B
6.33
P/C
381.77
P/FCF
37.61
Quick Ratio
0.26
Current Ratio
0.9
Debt / Equity
1.7
LT Debt / Equity
0.77
-
-
EPS (TTM)
3.03
EPS next Y
-
EPS next Q
-
EPS this Y
2550%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.51%
Revenue last 5Y
14.96%
Revenue Q/Q
-2.93%
EPS Q/Q
100%
-
-
-
-
SMA20
3.4%
SMA50
13.59%
SMA100
7.12%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
13%
ROC
0.06%
Gross Margin
75%
Oper. Margin
9%
Profit Margin
11%
Payout
94%
Shs Outstand
1.55B
Shs Float
1.54B
-
-
-
-
Target Price
-
52W Range
1164.5-1603.5
52W High
-0.69%
52W Low
+36.77%
RSI
67
Rel Volume
0.83
Avg Volume
263.9K
Volume
217.98K
Perf Week
2.35%
Perf Month
1.4%
Perf Quarter
10.44%
Perf Half Y
11.64%
-
-
-
-
Beta
0.178723
-
-
Volatility
6.39%, 26.02%
Prev Close
0.03%
Price
1592
Change
0.89%
AZN.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 17.43 | 18.74 | 20.29 | 26.39 | 28.65 | |
Net income per share | 1.7 | 1.03 | 2.44 | 0.08 | 2.12 | |
Operating cash flow per share | 2.07 | 2.28 | 3.66 | 4.21 | 6.34 | |
Free cash flow per share | 0.98 | 0.39 | 1.67 | 2.65 | 4.68 | |
Cash per share | 4.38 | 4.78 | 6.09 | 4.51 | 4.14 | |
Book value per share | 9.84 | 10.09 | 11.91 | 27.69 | 23.93 | |
Tangible book value per share | -15.49 | -13.76 | -13.07 | -16.29 | -14.26 | |
Share holders equity per share | 9.84 | 10.09 | 11.91 | 27.69 | 23.93 | |
Interest debt per share | 16.16 | 15.11 | 16.53 | 22.62 | 19.75 | |
Market cap | 96.57B | 130.54B | 129.25B | 166.58B | 207.69B | |
Enterprise value | 110.93B | 143.4B | 141.8B | 191.04B | 230.76B | |
P/E ratio | 44.81 | 97.78 | 40.44 | 1.49K | 63.17 | |
Price to sales ratio | 4.37 | 5.35 | 4.86 | 4.45 | 4.68 | |
POCF ratio | 36.89 | 43.97 | 26.93 | 27.94 | 21.18 | |
PFCF ratio | 77.44 | 256.46 | 58.94 | 44.27 | 28.7 | |
P/B Ratio | 7.75 | 9.94 | 8.27 | 4.24 | 5.61 | |
PTB ratio | 7.75 | 9.94 | 8.27 | 4.24 | 5.61 | |
EV to sales | 5.02 | 5.88 | 5.33 | 5.11 | 5.2 | |
Enterprise value over EBITDA | 15.37 | 20.44 | 16.94 | 25.25 | 24.74 | |
EV to operating cash flow | 42.37 | 48.3 | 29.55 | 32.04 | 23.53 | |
EV to free cash flow | 88.96 | 281.72 | 64.66 | 50.77 | 31.89 | |
Earnings yield | 0.02 | 0.01 | 0.02 | 0 | 0.02 | |
Free cash flow yield | 0.01 | 0 | 0.02 | 0.02 | 0.03 | |
Debt to equity | 3.74 | 3.56 | 3.27 | 1.68 | 1.6 | |
Debt to assets | 0.77 | 0.76 | 0.77 | 0.63 | 0.62 | |
Net debt to EBITDA | 1.99 | 1.83 | 1.5 | 3.23 | 2.47 | |
Current ratio | 0.96 | 0.86 | 0.96 | 1.16 | 0.86 | |
Interest coverage | 1.11 | 2.04 | 3.95 | 0.81 | 2.79 | |
Income quality | 1.21 | 1.92 | 1.23 | -22.5 | 3.92 | |
Dividend Yield | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | |
Payout ratio | 1.62 | 2.69 | 1.12 | 34.43 | 1.33 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.27 | 0.24 | 0.23 | 0.26 | 0.22 | |
Intangibles to total assets | 0.56 | 0.53 | 0.49 | 0.59 | 0.61 | |
Capex to operating cash flow | -0.52 | -0.83 | -0.54 | -0.37 | -0.26 | |
Capex to revenue | -0.06 | -0.1 | -0.1 | -0.06 | -0.06 | |
Capex to depreciation | -0.37 | -0.65 | -0.83 | -0.34 | -0.47 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 19.41 | 15.26 | 25.55 | 7.02 | 33.81 | |
ROIC | 0.03 | 0.06 | 0.12 | -0.01 | 0.08 | |
Return on tangible assets | 0.08 | 0.05 | 0.09 | 0 | 0.09 | |
Graham Net | -31.26 | -29.95 | -31.32 | -38.92 | -32.73 | |
Working capital | -701M | -2.55B | -763M | 3.65B | -3.7B | |
Tangible asset value | -19.62B | -17.91B | -17.15B | -23.1B | -22.07B | |
Net current asset value | -31.02B | -31.22B | -31.55B | -39.83B | -36.83B | |
Invested capital | 1.53 | 1.39 | 1.3 | 0.78 | 0.79 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 2.67B | 7.85B | 14.89B | 17.36B | 18.99B | |
Average inventory | 2.96B | 3.04B | 3.61B | 6.5B | 6.84B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 127.19 | 1.04K | 1.09K | 555.79 | 560.86 | |
Days of inventory on hand | 213.71 | 236.83 | 277.18 | 263.63 | 138.42 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 2.87 | 0.35 | 0.34 | 0.66 | 0.65 | |
Inventory turnover | 1.71 | 1.54 | 1.32 | 1.38 | 2.64 | |
ROE | 0.17 | 0.1 | 0.2 | 0 | 0.09 | |
Capex per share | -1.08 | -1.89 | -1.99 | -1.55 | -1.66 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 7.36 | 6.95 | 7.09 | 7.23 | 7.02 | |
Net income per share | 0.25 | 0.23 | 1.06 | 0.58 | 1.16 | |
Operating cash flow per share | 2.09 | 0.81 | 1.89 | 1.55 | 2.02 | |
Free cash flow per share | 1.85 | 0.46 | 1.18 | 1.19 | 1.07 | |
Cash per share | 3.76 | 3.15 | 3.16 | 4.13 | 4.17 | |
Book value per share | 23.48 | 23.2 | 22.7 | 23.91 | 23.1 | |
Tangible book value per share | -16.07 | -15.35 | -15.59 | -14.25 | -15.16 | |
Share holders equity per share | 23.48 | 23.2 | 22.7 | 23.91 | 23.1 | |
Interest debt per share | 20.31 | 19.26 | 19.15 | 19.1 | 20.57 | |
Market cap | 204.49B | 192.52B | 172B | 207.82B | 215.89B | |
Enterprise value | 229.82B | 217.23B | 196.85B | 230.89B | 241.16B | |
P/E ratio | 132.44 | 133.69 | 26.22 | 57.66 | 29.93 | |
Price to sales ratio | 17.95 | 17.87 | 15.66 | 18.54 | 19.84 | |
POCF ratio | 63.27 | 154.26 | 58.7 | 86.67 | 68.91 | |
PFCF ratio | 71.27 | 273.07 | 94.56 | 112.7 | 129.82 | |
P/B Ratio | 5.63 | 5.36 | 4.9 | 5.61 | 6.03 | |
PTB ratio | 5.63 | 5.36 | 4.9 | 5.61 | 6.03 | |
EV to sales | 20.18 | 20.17 | 17.92 | 20.6 | 22.17 | |
Enterprise value over EBITDA | 104.56 | 113.43 | 71.35 | 202.89 | 62.03 | |
EV to operating cash flow | 71.11 | 174.06 | 67.18 | 96.28 | 76.97 | |
EV to free cash flow | 80.11 | 308.12 | 108.22 | 125.21 | 145.02 | |
Earnings yield | 0 | 0 | 0.01 | 0 | 0.01 | |
Free cash flow yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 1.76 | 1.69 | 1.68 | 1.6 | 1.7 | |
Debt to assets | 0.64 | 0.63 | 0.63 | 0.62 | 0.63 | |
Net debt to EBITDA | 11.53 | 12.9 | 9 | 20.27 | 6.5 | |
Current ratio | 1 | 0.96 | 0.81 | 0.86 | 0.9 | |
Interest coverage | 2.61 | 1.73 | 3.67 | -0.95 | 6.98 | |
Income quality | 5.84 | 5.05 | 3.17 | 3.08 | 1.39 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0 | 0.01 | |
Payout ratio | 7.7 | 0 | 0.85 | 0 | 1.69 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.19 | 0.24 | 0.21 | 0.23 | 0.24 | |
Intangibles to total assets | 0.61 | 0.62 | 0.63 | 0.61 | 0.61 | |
Capex to operating cash flow | -0.11 | -0.44 | -0.38 | -0.23 | -0.47 | |
Capex to revenue | -0.03 | -0.05 | -0.1 | -0.05 | -0.14 | |
Capex to depreciation | -0.28 | -0.4 | -0.83 | -0.37 | -0.98 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 11.48 | 11.01 | 23.26 | 17.69 | 24.6 | |
ROIC | 0.01 | 0.01 | 0.03 | -0.01 | 0.03 | |
Return on tangible assets | 0.01 | 0.01 | 0.05 | 0.02 | 0.05 | |
Graham Net | -35.06 | -33.98 | -33.33 | -32.71 | -33.53 | |
Working capital | -93M | -898M | -4.63B | -3.7B | -2.59B | |
Tangible asset value | -24.87B | -23.77B | -24.14B | -22.07B | -23.48B | |
Net current asset value | -41.27B | -39.71B | -38.81B | -36.83B | -38.61B | |
Invested capital | 0.86 | 0.82 | 0.83 | 0.79 | 0.88 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 18.4B | 17.84B | 17.76B | 18.37B | 19.13B | |
Average inventory | 8.3B | 6.92B | 5.65B | 4.89B | 4.83B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 457.92 | 534.99 | 534.02 | 590.9 | 907.56 | |
Days of inventory on hand | 195.43 | 186.72 | 153.26 | 145.83 | 234.66 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.2 | 0.17 | 0.17 | 0.15 | 0.1 | |
Inventory turnover | 0.46 | 0.48 | 0.59 | 0.62 | 0.38 | |
ROE | 0.01 | 0.01 | 0.05 | 0.02 | 0.05 | |
Capex per share | -0.23 | -0.35 | -0.72 | -0.36 | -0.95 |
AZN.ST Frequently Asked Questions
What is AstraZeneca PLC stock symbol ?
AstraZeneca PLC is a GB stock and trading under the symbol AZN.ST
What is AstraZeneca PLC stock quote today ?
AstraZeneca PLC stock price is $1592 today.
Is AstraZeneca PLC stock public?
Yes, AstraZeneca PLC is a publicly traded company.